Relypsa launches new hyperkalemia med Veltassa; Samsung aims for CMO dominance;

@FiercePharma: Gene-testing business boosts Neogen's sales but earnings fall short of high expectations. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: WuXi clarifies just what AstraZeneca is buying, or actually what it isn't buying. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce

> Relypsa's ($RLYP) new hyperkalemia treatment Veltassa rolled onto the U.S. market Monday; it won FDA approval in October. Release

> Samsung's heir apparent appeared at a groundbreaking for a new biologics manufacturing plant Monday, underscoring the company's big bet on biopharma. Report

> Chinese drugmaker Shanghai Fosun Pharma's biotech unit plans an IPO in Hong Kong. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: Philips' Volcano to keep Sacramento site despite 60 manufacturing layoffs. Article | Follow @FierceMedDev

@EmilyWFierce: Hey doc, what's on the menu when pharma comes calling? Hint: It's not health food. Story from FiercePharmaMarketing | Follow @EmilyWFierce

> DOJ settles with 32 hospitals for $105M over improper Medicare billing related to spinal surgery. Article

> Regulators probe complaints from former Theranos employees over lab, testing practices: WSJ. More

Biotech News

@FierceBiotech: As trouble mounts, a chastened Martin Shkreli says bad boy persona was just an 'experiment.' Article | Follow @FierceBiotech

@JohnCFierce: Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis. (What breakthrough?) More | Follow @JohnCFierce

> Eli Lilly taps Halozyme in an $825M delivery deal. News

> Amgen buys another cancer-fighting virus project in a $10.5M deal. Report

Pharma Marketing News

> New FDA policy gives its staff wide latitude on social media. Could pharma freedom follow? More

> Hey doc, what's on the menu when pharma comes calling? Hint: It's not health food. Story

> Bayer, coveting top spots in animal and consumer health, may eye deals for Zoetis, Pfizer OTC. Item

> Headaches for Reckitt over charges of misleading claims for OTC painkillers. Article

Animal Health News

> Sanofi, Boehringer to create new animal health giant in $12.5B asset swap. News

> U.S. states lift bird-flu bans and quarantines as reports of virus mount overseas. Article

> Jaguar shares jump on string of positive news in equine health. Report

> AB Science's Kinavet cancer drug for dogs loses FDA marketing authorization. Item

> Toxin from sea algae impacts memory, behavior in California sea lions: Study. More

Biotech IT News

> Shkreli's Twitter account hacked, spokesperson says. Item

> UCB taps Congenica tech for help with target discovery. News

> MorphoSys picks Dotmatics tool to visualize, analyze screening data. Report

> FDA hits tight timeline for start of precisionFDA open beta. More

> FDA CTO admits security shortcomings are holding back data sharing. Article

And Finally... Proton-pump inhibitors, routinely prescribed to hospitalized patients, may raise the risk of death. More

Suggested Articles

Esperion's Nexletol has had a rough road to approval after safety concerns nearly derailed its quest. But an FDA nod has the drug ready for market.

In an interview with Israel's Calcalist, Teva CEO Kåre Schultz shared details of his approach to the company's turnaround.

Nerlynx is already struggling in its extended adjuvant breast cancer setting, and new entrants from Daiichi-AZ and SeaGen could pressure it elsewhere.